1-3 of 3
Pascaline Talmant, MD
Close
Sort by
Journal Articles

Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.

Jacques Delaunay, MD, Raouf Ben Abdelali, MD, Cyrille Touzeau, MD, Patrice Chevallier, MD, Guillaume Thierry, MD, Steven Le Gouill, MD, PhD, Sameh Ayari, MD, Jean-Luc Harousseau, MD, Elisabeth Macintyre, MD, PhD, Herve Avet Loiseau, MD, PhD, Herve Dombret, MD, Pascaline Talmant, MD
Journal: Blood
Blood (2007) 110 (11): 4329.
https://doi.org/10.1182/blood.V110.11.4329.4329
Published: 2007
Journal Articles

Prognostic Value of Cytogenetics in Patients with Acute Myeloid Leukemia Aged More Than 60 Years at Diagnosis: Identification of Subgroups Taking Benefit from Intensive Chemotherapy. Results from a Large Single Center Retrospective Study.

Nicolas Blin, MD, Pascaline Talmant, MD, Richard Garand, MD, Francoise Accard, MD, Philippe Moreau, MD, Jean-Luc Harousseau, MD, Herve Avet-Loiseau, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3503.
https://doi.org/10.1182/blood.V110.11.3503.3503
Published: 2007
Journal Articles

The t(14;19)(q32;q13) Translocation in B Lymphoproliferative Disorders: A Continuum from Chronic Lymphocytic Leukemia (CLL) to Marginal Zone Lymphoma (MZL)?.

Florence Nguyen-Khac, MD, PhD, Elise Chapiro, MD, Isabelle Radford-Weiss, MD, Christian Bastard, MD,PhD, Leroux Dominique, MD,PhD, Evelyne Callet-Bauchu, MD,PhD, Pascaline Talmant, MD, Isabelle Luquet, MD,PhD, Mozziconacci Marie-Joelle, MD,PhD, Lessard Michel, MD,PhD, Raynaud D. Sophie, MD,PhD, Frederic Davi, MD,PhD, Helene Merle-Beral, MD,PhD, Francoise Berger, MD,PhD, Roland Berger, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 4944.
https://doi.org/10.1182/blood.V108.11.4944.4944
Published: 2006